Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) Virus

Clinical Infectious Diseases

Volumn 57, Issue 10, 2013, Pages 1449-1457

  Yu, Liang ^a   Wang, Zhaoming ^b   Chen, Yu ^a   Ding, Wei ^b   Jia, Hongyu ^a   Chan, Jasper Fuk Woo ^c   To, Kelvin Kai Wang ^c   Chen, Honglin ^a,c   Yang, Yida ^a   Liang, Weifeng ^a   Zheng, Shufa ^a   Yao, Hangping ^a   Yang, Shigui ^a   Cao, Hongcui ^a   Dai, Xiahong ^a   Zhao, Hong ^a   Li, Ju ^d   Bao, Qiongling ^a   Chen, Ping ^a   Hou, Xiaoli ^e   Li, Lanjuan ^a   Yuen, Kwok Yung ^a,c   more..

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c THE UNIVERSITY OF HONG KONG   (Hong Kong)

^d First Affiliated Hospital   (China)

^e ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

Author keywords

Avian; Clinical; H7N9; Histopathology; Influenza

Indexed keywords

HEMAGGLUTINATION INHIBITING ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; ATROPHY; AVIAN INFLUENZA; AVIAN INFLUENZA VIRUS; BACTERIAL INFECTION; BONE MARROW BIOPSY; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE COURSE; ERYTHROPHAGOCYTOSIS; FATALITY; FEMALE; HEART MUSCLE BIOPSY; HISTOPATHOLOGY; HOSPITAL INFECTION; HUMAN; HUMAN TISSUE; INTENSIVE CARE UNIT; KIDNEY BIOPSY; LEUKOPENIA; LIVER BIOPSY; LIVER FUNCTION; LUNG BIOPSY; LUNG HEMORRHAGE; LYMPHOCYTOPENIA; MALE; PRIORITY JOURNAL; RESPIRATORY SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN BIOPSY; SURVIVOR; THROMBOCYTOPENIA; VIROLOGY; VIRUS LOAD;

AVIAN; CLINICAL; H7N9; HISTOPATHOLOGY; INFLUENZA;

ADULT; AGED; ANTIBODIES, VIRAL; COHORT STUDIES; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HISTOCYTOCHEMISTRY; HUMANS; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA, HUMAN; LUNG; MALE; MIDDLE AGED; NASOPHARYNX; SPUTUM; STATISTICS, NONPARAMETRIC;

EID: 84884677405     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit541     Document Type: Article

References (34)

1. Yuen KY, Chan PK, Peiris M, et al Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998; 351: 467-71.
2. To KK, Ng KH, Que T.L., et al Avian influenza A H5N1 virus: a continuous threat to humans. Emerg Microbes Infect 2012; 1: e25.
3. Chen Y, Liang W, Yang S., et al Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet 2013; 381: 1916-25.
4. Gao R, Cao B, Hu Y., et al Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 2013; 368: 1888-97.
5. To KK, Chan JF, Chen H, et al The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities. Lancet Infect Dis 2013; 13: 809-21.
6. Chan JF, To KK, Tse H, et al Interspecies transmission and emergence of novel viruses: lessons from bats and birds. Trends Microbiol 2013. doi:pii: S0966-842X(13)00089-9.
7. Yang S, Chen Y, Cui D., et al Avian-origin H7N9 virus infection in H7N9-affected areas of China: a serological study. J Infect Dis 2013. [Epub ahead of print].
8. World Health Organization. Human infection with avian influenza A (H7N9) virus-update, 4 July 2013. Available at: http://www.who.int/csr/don/2013-07-04/ en/index.html. Accessed 20 July 2013.
9. Koopmans M, Wilbrink B, Conyn M., et al Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 2004; 363: 587-93.
10. Gao HN, Lu HZ, Cao B, et al Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med 2013; 368: 2277-85.
11. Xu C, Havers F, Wang L., et al Monitoring avian influenza A(H7N9) virus through national influenza-like illness surveillance, China. Emerg Infect Dis 2013; 19. doi:10.3201/eid1908.130662.
12. Knaus WA, Draper EA, Wagner D.P., Zimmerman JE APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-29.
13. Bernard GR, Artigas A, Brigham K.L., et al The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-24.
14. Taylor FB J.r., Toh CH, Hoots W.K., et al Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86: 1327-30.
15. To KK, Hung IF, Li I.W., et al Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis 2010; 50: 850-9.
16. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 19th informational supplement. CLSI document M100-S22. Wayne, PA: CLSI, 2012.
17. Ho PL, Ho AY, Chow K.H., Cheng VC Surveillance for multidrug-resistant Acinetobacter baumannii: a lesson on definitions. Int J Antimicrob Agents 2010; 36: 469-71.
18. Chan KH, To KK, Hung I.F., et al Differences in antibody responses of individuals with natural infection and those vaccinated against pandemic H1N1 2009 influenza. Clin Vaccine Immunol 2011; 18: 867-73.
19. Zheng BJ, Chan KW, Lin Y.P., et al Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus. Proc Natl Acad Sci U S A. 2008; 105: 8091-6.
20. Chan KH, Zhang AJ, To K.K., et al Wild type and mutant 2009 pandemic influenza A (H1N1) viruses cause more severe disease and higher mortality in pregnant BALB/c mice. PLos One 2010; 5: e13757.
21. Zheng B, Chan KH, Zhang A.J., et al D225G mutation in hemagglutinin of pandemic influenza H1N1 (2009) virus enhances virulence in mice. Exp Biol Med (Maywood). 2010; 235: 981-8.
22. Zhang Z, Zhang J, Huang K., et al Systemic infection of avian influenza A virus H5N1 subtype in humans. Hum Pathol 2009; 40: 735-9.
23. World Health Organization. Overview of the emergence and characteristics of the avian influenza A(H7N9) virus. Available at: http://www.who.int/ influenza/human-animal-interface/influenza-h7n9/WHO-H7N9-review-31May13.pdf. Accessed 1 June 2013.
24. Hu Y, Lu S, Song Z., et al Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet 2013; 381: 2273-9.
25. Korteweg C, Gu J. Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am J Pathol 2008; 172: 1155-70.
26. Gu J, Xie Z, Gao Z., et al H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet 2007; 370: 1137-45.
27. Piwpankaew Y, Monteerarat Y, Suptawiwat O., Puthavathana P, Uipresertkul M, Auewarakul P. Distribution of viral RNA, sialic acid receptor, and pathology in H5N1 avian influenza patients. APMIS 2010; 118: 895-902.
28. Ku AS, Chan LT The first case of H5N1 avian influenza infection in a human with complications of adult respiratory distress syndrome and Reye's syndrome. J Paediatr Child Health 1999; 35: 207-9.
29. Tse H, To KK, Wen X, et al Clinical and virological factors associated with viremia in pandemic influenza A/H1N1/2009 virus infection. PLoS One 2011; 6: e22534.
30. Dilantika C, Sedyaningsih ER, Kasper M.R., et al Influenza virus infection among pediatric patients reporting diarrhea and influenza-like illness. BMC Infect Dis 2010; 10: 3.
31. Buchy P, Mardy S, Vong S., et al Influenza A/H5N1 virus infection in humans in Cambodia. J Clin Virol 2007; 39: 164-8.
32. de Jong M.D., Simmons CP, Thanh T.T., et al Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006; 12: 1203-7.
33. Rowe T, Abernathy RA, Hu-Primmer J, et al Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 1999; 37: 937-43.
34. Muthuri SG, Myles PR, Venkatesan S, Leonardi-Bee J, Nguyen-Van-Tam JS. Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-2010 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients. J Infect Dis 2013; 207: 553-63.